Allurion Technologies, Inc. (ALUR)

Price$0.88

Value ScoreB

Growth ScoreF

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-56.76%

Price vs S&P 500 (4W)25.87%

VGM Score44.40

Market Capitalization$13.07M

All Metrics

Book Value / Share (Quarterly)$-1.11

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-38.10%

Cash Flow / Share (Quarterly)$0.42

Price vs S&P 500 (YTD)-39.52%

Gross Margin (TTM)52.70%

Net Profit Margin (TTM)-264.74%

EPS (TTM)$-3.85

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-3.85

EPS (Annual)$-3.81

ROI (Annual)-39.99%

Gross Margin (Annual)62.84%

Net Profit Margin (5Y Avg)-90.63%

Cash / Share (Quarterly)$0.34

Revenue Growth QoQ (YoY)-47.19%

ROA (Last FY)-182.32%

Revenue Growth TTM (YoY)-55.49%

EBITD / Share (TTM)$-2.77

Operating Margin (TTM)-216.46%

Cash Flow / Share (Annual)$-2.36

Net Income / Employee (Annual)$-756,700

EV / Revenue (TTM)2.90x

Net Interest Coverage (TTM)-1.46x

ROA (TTM)-175.34%

EPS Incl Extra (Annual)$-3.81

Current Ratio (Annual)0.33x

Quick Ratio (Quarterly)0.23x

3-Month Avg Trading Volume1.83M

52-Week Price Return-69.25%

Revenue / Employee (TTM)$331,500

Tangible BV / Share (Quarterly)$-1.11

P/S Ratio (Annual)0.86x

Asset Turnover (Annual)0.97x

52-Week High$3.33

Operating Margin (5Y Avg)-131.53%

EPS Excl Extra (Annual)$-3.81

26-Week Price Return-45.37%

Quick Ratio (Annual)0.24x

13-Week Price Return15.91%

Total Debt / Equity (Annual)5.40x

Current Ratio (Quarterly)0.30x

Enterprise Value$36.56M

Asset Turnover (TTM)0.66x

Revenue / Employee (Annual)$400,800

Inventory Turnover (Annual)1.86x

Pretax Margin (Annual)-188.32%

Cash / Share (Annual)$0.44

3-Month Return Std Dev248.13%

Gross Margin (5Y Avg)72.55%

Net Income / Employee (TTM)$-877,600

ROE (Last FY)-255.99%

Net Interest Coverage (Annual)-1.28x

EPS Basic Excl Extra (Annual)$-3.81

Receivables Turnover (TTM)2.14x

EV / Free Cash Flow (TTM)5.85x

EPS Incl Extra (TTM)$-3.85

Receivables Turnover (Annual)2.75x

P/S Ratio (TTM)1.04x

Pretax Margin (5Y Avg)-89.95%

Revenue / Share (Annual)$2.02

Tangible BV / Share (Annual)$-0.76

Price vs S&P 500 (52W)-96.29%

Year-to-Date Return-28.50%

5-Day Price Return23.87%

EPS Normalized (Annual)$-3.81

ROA (5Y Avg)-84.32%

Net Profit Margin (Annual)-188.80%

Month-to-Date Return23.87%

Cash Flow / Share (TTM)$-1.74

EBITD / Share (Annual)$-4.02

Operating Margin (Annual)-202.34%

LT Debt / Equity (Annual)0.41x

P/CF (TTM)2.09x

EPS Basic Excl Extra (TTM)$-3.85

Inventory Turnover (TTM)2.20x

Pretax Margin (TTM)-264.73%

Book Value / Share (Annual)$-0.76

Price vs S&P 500 (13W)5.40%

Beta-0.24x

Revenue / Share (TTM)$0.94

52-Week Low$0.23

vGradeB

gGradeF

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.15est. -0.35

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

4.25

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
ALURAllurion Technologies, Inc.	B	F	C	$0.88
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

Allurion Technologies develops a minimally invasive weight loss platform centered on the Allurion Balloon, a swallowable intragastric balloon that requires no surgery, endoscopy, or anesthesia. The platform combines the proprietary balloon with AI-powered remote patient monitoring, a behavior modification program, and virtual care services delivered through its proprietary Allurion VCS. This non-procedural approach addresses a significant market opportunity in weight management for overweight patients seeking alternatives to invasive interventions.